SecBot SecBot
8-K ·Filed Jul 31, 2026

INO

INOVIO PHARMACEUTICALS, INC.
BEARISH
Impact 6/10
Horizonimmediate Processed3mo ago SEC0001193125-26-326785
8-K material event: Items 1.01
Actionable Insight ▼ Bearish

The offering provides near-term cash but at significant dilution and with a large warrant overhang. Monitor the October 30 PDUFA date for INO-3107 and any updates on cash runway. The stock may face continued pressure from the overhang of 48.4M exercisable warrants at $1.10.

DirectionBearish
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$0.6770
T+0 close · Jul 31, 2026 · via day close
Latest settled
+28.48%
T+60 · $0.8698
Vs SPY
+26.02%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 31 $0.6770entry
  2. T+1 · 4mo ago +2.92%α +1.50% · $0.6968
  3. T+5 · 3mo ago −1.33%α −4.84% · $0.6680
  4. T+20 · 3mo ago +90.55%α +87.56% · $1.29
  5. T+60 · 22d ago +28.48%α +26.02% · $0.8698
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Inovio Pharmaceuticals priced a $20M public offering of 21M shares and warrants for 42M shares (or pre-funded warrants) at $0.95/unit, with net proceeds of ~$18.3M. The underwriter exercised an option for additional warrants covering 6.3M shares. This dilutive capital raise follows a prior going-concern disclosure and adds ~30% immediate dilution plus significant warrant overhang, reinforcing the bearish outlook.

Key Facts

  • Offering of 21,052,632 shares and warrants to purchase up to 42,105,264 shares at $0.95/unit
  • Underwriter exercised option for warrants to purchase an additional 6,315,788 shares
  • Net proceeds expected to be approximately $18.3 million
  • Warrants have a $1.10 exercise price, 5-year term, with beneficial ownership limitations
  • Offering priced at ~8% discount to the prior close of $1.03
  • Company previously disclosed going-concern risk in the related 424B5 filing

Financial Impact

Immediate dilution of ~30% from shares alone; potential further dilution from warrants (up to 48.4M additional shares if exercised). Net cash infusion of ~$18.3M against an $86M market cap.

dilutioncashshare count

Risk Factors

  • Substantial dilution from shares and warrants
  • Going-concern risk as previously disclosed
  • Warrant overhang may cap upside
  • Dependence on INO-3107 regulatory outcome

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
67% bullish (9 analysts)

Investment Themes

Documents Analyzed

This report is based on 10 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-326785
Document: d253972dex42.htm0001193125-26-326785
Document: d253972dex41.htm0001193125-26-326785
Document: d253972d8k.htm0001193125-26-326785
Document: d253972dex51.htm0001193125-26-326785
Document: d253972dex992.htm0001193125-26-326785
Document: d253972dex991.htm0001193125-26-326785
Document: 0001193125-26-326785-index-headers.html0001193125-26-326785
Document: 0001193125-26-326785-index.html0001193125-26-326785
Document: 0001193125-26-326785.txt0001193125-26-326785

Track record

20 reports on INO

Performance horizon

7 of 13 bullish or bearish reports moved the stock their way by T+5. Best: +46.23% at T+20 after the Jul 2, 2026 report. 8 of 14 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 4/10 Entry $1.39 Now $1.40 +0.72% settles Nov 24
  2. Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $1.40 Now $1.40 −0.01% settles Nov 24
  3. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $1.41 Now $1.40 −0.71% settles Nov 23
  4. Nov 10, 20266d ago 8-K Bearish 5/10 Entry $1.48 Now $1.40 +5.08% settles Nov 18
  5. Nov 9, 20267d ago 8-K Bearish 5/10 Entry $1.51 to $1.40 Now $1.40 +7.28% ▲ +7.28% +5.59% vs SPY
  6. Nov 6, 202610d ago 424B5 Bearish 5/10 Entry $1.51 to $1.40 Now $1.40 +7.28% ▲ +7.28% +5.59% vs SPY
  7. Nov 5, 202611d ago Press Release Bearish 6/10 Entry $1.22 to $1.43 Now $1.40 −15.23% ▼ −17.70% −15.10% vs SPY
  8. Nov 5, 202611d ago 8-K Bearish 5/10 Entry $1.22 to $1.43 Now $1.40 −15.23% ▼ −17.70% −15.10% vs SPY
  9. Nov 5, 202611d ago 424B5 Bearish 4/10 Entry $1.22 to $1.43 Now $1.40 −15.23% ▼ −17.70% −15.10% vs SPY
  10. Nov 5, 202611d ago Press Release Bearish 4/10 Entry $1.22 to $1.43 Now $1.40 −15.23% ▼ −17.70% −15.10% vs SPY
Showing 10 of 20

US Market Status

Market Closed · Opens in 6h 7m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 31, 2026